A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and pharmacodynamics of
saxagliptin administered before breakfast for 14 consecutive days in patients with type 2
diabetes mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.